Zydus Lifesciences Limited Ramipril Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Ramipril Export Records India — #14 Exporter, 56 Shipments, $999.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Zydus Lifesciences Limited — Ramipril Exporter #14 | $999.7K Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Ramipril Exporter Profile

Indian Pharmaceutical Exporter · #14 for Ramipril · $999.7K export value · DGFT Verified

Zydus Lifesciences Limited is the #14 Indian exporter of Ramipril with $999.7K in export value and 56 verified shipments. Zydus Lifesciences Limited holds a 1.1% market share in Ramipril exports across 1 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Ramipril Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Ramipril export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ramipril?

Country	Value	Shipments	Share
UNITED KINGDOM	$31.4M	1,302	36.4%
FRANCE	$20.8M	549	24.1%
UNITED STATES	$12.9M	611	14.9%
CANADA	$5.6M	514	6.4%

Who Are the Top Buyers of Ramipril from India?

Buyer	Country	Value	Orders
WOCKHARDT UK LIMITED	UNITED KINGDOM	$6.7M	276
CRESCENT PHARMA LTD	UNITED KINGDOM	$5.8M	191
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$4.0M	125
ZENTIVA ITALIA SRL	ITALY	$3.8M	169
M/S CRESCENT PHARMA LTD.	UNITED KINGDOM	$3.1M	208
MILPHARM LIMITED,	UNITED KINGDOM	$2.6M	52
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$2.2M	44
APOTEX INC,	CANADA	$1.8M	45
SANOFI SAGLIK URUNLERI LTD STI	TURKEY	$1.1M	22
CSP VIATRIS SANT? AT CSP- LAB	FRANCE	$1.0M	20

India's Ramipril is purchased by 389 buyers worldwide. The top buyer is WOCKHARDT UK LIMITED (UNITED KINGDOM), followed by CRESCENT PHARMA LTD and BROWN AND BURK UK LIMITED.

How Does Zydus Lifesciences Limited Compare to Nearest Ramipril Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	IPCA LABORATORIES LIMITED	$1.3M	244	5	$5.4K
13	IND-SWIFT LIMITED	$1.2M	42	2	$28.1K
14	ZYDUS LIFESCIENCES LIMITED ★	$999.7K	56	1	$17.9K
15	AJANTA PHARMA LIMITED	$937.2K	68	5	$13.8K

Zydus Lifesciences Limited ranks #14 among 177 Indian Ramipril exporters. Average shipment value of $17.9K compared to the market average of $466.2K. The closest competitors by value are IPCA LABORATORIES LIMITED and IND-SWIFT LIMITED.

Which Indian Ports Ship Ramipril Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	658	13.2%
JNPT/ NHAVA SHEVA SEA	553	11.1%
SAHAR AIR CARGO ACC (INBOM4)	305	6.1%
SAHAR AIR	291	5.8%
JNPT	271	5.4%
DELHI AIR CARGO ACC (INDEL4)	214	4.3%
DELHI AIR	201	4.0%
VIZAG SEA	194	3.9%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Ramipril Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 389+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ramipril

Ramipril

Zydus Lifesciences Limited — Ramipril Exporter Profile

Zydus Lifesciences Limited — Ramipril Export Profile: Buyers & Destinations

Where Does India Export Ramipril?

Who Are the Top Buyers of Ramipril from India?

What Is India's Total Ramipril Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Ramipril Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Ramipril Exporters?

Regulatory Requirements: Exporting Ramipril to Key Markets

United Kingdom — MHRA

United States — FDA

How Does Zydus Lifesciences Limited Compare to Nearest Ramipril Exporters?

Which Indian Ports Ship Ramipril Exports?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Ramipril Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ramipril Export Data from Zydus Lifesciences Limited

Ramipril Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source